Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.

RPEP-128422025Oe, Yuki; Nomoto, Hiroshi; Cho, Kyu Yong; Omori, Takashi; Nakamura, Koki; Takahashi, Akihiro; Suzuki, Yuka; Yoshikawa, Jyunpei; Kato-Sato, Akiko; Furukawa, Shin; Nishio, Taro; Kitakawa, Hirohiko; Miya, Aika; Kameda, Hiraku; Nakazawa, Daigo; Nakamura, Akinobu; Sakai, Kiyoshi; Atsumi, Tatsuya

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.

Therapeutic advances in endocrinology and metabolism, 16, 20420188251378216

View on PubMed ↗Publisher’s paper ↗

Citation

Oe, Yuki; Nomoto, Hiroshi; Cho, Kyu Yong; Omori, Takashi; Nakamura, Koki; Takahashi, Akihiro; Suzuki, Yuka; Yoshikawa, Jyunpei; Kato-Sato, Akiko; Furukawa, Shin; Nishio, Taro; Kitakawa, Hirohiko; Miya, Aika; Kameda, Hiraku; Nakazawa, Daigo; Nakamura, Akinobu; Sakai, Kiyoshi; Atsumi, Tatsuya. (2025). Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.. Therapeutic advances in endocrinology and metabolism, 16, 20420188251378216. https://doi.org/10.1177/20420188251378216